No single drug delivery partnership model can be applied across all drug delivery partnerships. Partnering around drug delivery technology can occur at different stages of the drug development and commercialization lifecycle, requiring varying levels of collaboration and involving multiple different partners and their respective interests.
The degree of intended collaboration between drug delivery technology partners has declined over the past five years. Big pharma has become an increasingly important source for high value licensing investment in novel drug delivery technologies.
This report builds on interviews with industry executives, case studies, and analysis of deal and other market data to set out a set of strategies to optimally partner for enhanced drug delivery products.
Features and benefits
Your key questions answered
View the complete report @ http://www.reportsnreports.com/reports/150506-drug-delivery-partnership-strategies.html
Released On: 9/3/2012
Views: 3192
Released On: 8/31/2012
Views: 3917
Released On: 8/27/2012
Views: 2203
Released On: 8/23/2012
Views: 3063
Released On: 8/23/2012
Views: 2107
Released On: 8/21/2012
Views: 2783
Released On: 8/16/2012
Views: 3434
Released On: 8/16/2012
Views: 2036
Released On: 8/16/2012
Views: 4279
Released On: 8/14/2012
Views: 2167
Released On: 8/14/2012
Views: 1862